Poder TG - Search Results

1

Early introduction without screening is a good deal, if caregivers will buy it.

Upton JEM, Poder TG, Begin P. Upton JEM, et al. Among authors: poder tg. Allergy. 2019 Feb;74(2):213-215. doi: 10.1111/all.13584. Allergy. 2019. PMID: 30076601 No abstract available.

2

A systematic review of SF-6D health state valuation studies.

Wang L, Poder TG. Wang L, et al. Among authors: poder tg. J Med Econ. 2023 Jan-Dec;26(1):584-593. doi: 10.1080/13696998.2023.2195753. J Med Econ. 2023. PMID: 36973235 Free article. Review.

3

Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran.

Moradi N, Poder TG, Safari H, Mojahedian MM, Ameri H. Moradi N, et al. Among authors: poder tg. Front Oncol. 2022 Dec 9;12:1052155. doi: 10.3389/fonc.2022.1052155. eCollection 2022. Front Oncol. 2022. PMID: 36568223 Free PMC article.

4

Determination of a cost-effectiveness threshold for cancer interventions in Iran.

Safari H, Poder TG, Afshari S, Nahvijou A, Arab-Zozani M, Moradi N, Ameri H. Safari H, et al. Among authors: poder tg. Front Oncol. 2022 Dec 12;12:1039589. doi: 10.3389/fonc.2022.1039589. eCollection 2022. Front Oncol. 2022. PMID: 36578935 Free PMC article.

5

Canadian English translation and linguistic validation of the 13-MD to measure global health-related quality of life.

Poder TG, Touré M. Poder TG, et al. Expert Rev Pharmacoecon Outcomes Res. 2024 Feb;24(2):267-272. doi: 10.1080/14737167.2023.2268275. Epub 2024 Jan 25. Expert Rev Pharmacoecon Outcomes Res. 2024. PMID: 37800538

6

Adaptation of a standardized self-reported cost questionnaire specific for the severe burn injury population (BI-CoPaQ).

Espinoza-Moya ME, Laberge M, Bélanger L, Chang SL, Poder TG, Moulin VJ, Germain L, Beaudoin Cloutier C, Guertin JR. Espinoza-Moya ME, et al. Among authors: poder tg. Burns. 2024 Dec;50(9):107204. doi: 10.1016/j.burns.2024.07.008. Epub 2024 Jul 11. Burns. 2024. PMID: 39322506 Free article.

7

Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration.

Daroudi R, Zeraati H, Poder TG, Norman R, Olyaeemanesh A, Sari AA, Ameri H. Daroudi R, et al. Among authors: poder tg. Qual Life Res. 2024 Jul;33(7):1853-1863. doi: 10.1007/s11136-024-03649-5. Epub 2024 Apr 17. Qual Life Res. 2024. PMID: 38630166

8

Work stressors, work-family conflict, parents' depressive symptoms and perceived parental concern for their children's mental health during COVID-19 in Canada: a cross-sectional analysis.

Bilodeau J, Quesnel-Vallée A, Poder T. Bilodeau J, et al. BMC Public Health. 2023 Nov 7;23(1):2181. doi: 10.1186/s12889-023-17037-0. BMC Public Health. 2023. PMID: 37936129 Free PMC article.

9

The value of oral immunotherapy.

Dufresne É, Poder TG, Bégin P. Dufresne É, et al. Among authors: poder tg. Allergy. 2020 Jun;75(6):1291-1293. doi: 10.1111/all.14072. Allergy. 2020. PMID: 31579934 No abstract available.

10

Correction to: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy.

Langlois A, Lavergne MH, Leroux H, Killer K, Azzano P, Paradis L, Samaan K, Lacombe-Barrios J, Eiwegger T, Upton J, Sussman G, Poder T, Mâsse B, Roches AD, Bégin P. Langlois A, et al. Allergy Asthma Clin Immunol. 2020 May 20;16:38. doi: 10.1186/s13223-020-00435-z. eCollection 2020. Allergy Asthma Clin Immunol. 2020. PMID: 32477416 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters